Drug Type Small molecule drug |
Synonyms LU 42668, LU-42668 |
Target |
Action blockers |
Mechanism VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC34H52N2O2 |
InChIKeyPHFDAOXXIZOUIX-UHFFFAOYSA-N |
CAS Registry83200-10-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Anipamil | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypertension | Phase 3 | Austria | - | - |
| Hypertension | Phase 3 | Germany | - | |
| Hypertension | Phase 3 | - | - | |
| Myocardial Ischemia | Phase 3 | Uganda | - | - |
| Myocardial Ischemia | Phase 3 | - | - | |
| Atherosclerosis | Phase 1 | - | - |





